Mark Foletta

Track

Insider profile

Currently holds positions in Forte Biosciences, Inc., Amylin Pharmaceuticals LLC, AMN Healthcare Services Inc and Dexcom Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Forte Biosciences, Inc. Feb. 1, 2017 -
Chief Financial Officer, Senior Vice President - Finance Amylin Pharmaceuticals LLC March 1, 2006 -
Independent Director AMN Healthcare Services Inc Dec. 12, 2012 -
Lead Independent Director Dexcom Inc Nov. 1, 2015 -
Independent Director Regulus Therapeutics Inc Jan. 31, 2013 - April 1, 2018
Interim Chief Financial Officer Biocept Inc Aug. 21, 2015 - July 27, 2016
Independent Director Dexcom Inc Nov. 19, 2014 - Nov. 1, 2015
Mark Foletta's trades of Dexcom Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
369.08
Quantity 58,422 -43.9%
Value US$1,747,922
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
343.37
Quantity 56,697
Value US$112,895
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
86.42
Quantity 97,694 +48.1%
Value US$4,730,759
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
80.00
Quantity 2,000
Value US$160,000
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
74.82
Quantity 199 -0.4%
Value US$14,889
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
74.10
Quantity 3,801 -6.7%
Value US$281,651
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
75.70
Quantity 4,000
Value US$302,800
US Dexcom Inc (DXCM)
Transaction date
Sale
Price
81.54
Quantity 195 -0.4%
Value US$15,900
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
81.02
Quantity 2,555 -4.7%
Value US$207,003
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
80.29
Quantity 2,750
Value US$220,798
US Dexcom Inc (DXCM)
Transaction date
Sale
Price
86.03
Quantity 8 -0.0%
Value US$688
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
85.17
Quantity 2,742 -4.8%
Value US$233,528
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
86.03
Quantity 2,750
Value US$236,582
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
83.13
Quantity 2,750 -4.6%
Value US$228,605
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
82.80
Quantity 2,750
Value US$227,700
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
117.25
Quantity 299 -0.5%
Value US$35,056
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
116.75
Quantity 3,007 -5.0%
Value US$351,065
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
116.53
Quantity 3,306
Value US$385,248
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
117.77
Quantity 475 -0.8%
Value US$55,942
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
117.16
Quantity 2,212 -3.5%
Value US$259,159
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
115.18
Quantity 7 -0.0%
Value US$806
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
115.18
Quantity 2,694
Value US$310,295
US Dexcom Inc (DXCM)
Transaction date
Proposed sale
Price
113.65
Quantity 10,000
Value US$1,136,528
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
569.54
Quantity 41 -0.3%
Value US$23,351
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
567.35
Quantity 2 -0.0%
Value US$1,135
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
565.51
Quantity 87 -0.7%
Value US$49,200
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
564.24
Quantity 65 -0.5%
Value US$36,675
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
562.79
Quantity 116 -0.9%
Value US$65,283
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
561.85
Quantity 78 -0.6%
Value US$43,824
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
558.78
Quantity 70 -0.5%
Value US$39,115
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
556.89
Quantity 41 -0.3%
Value US$22,832
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
634.01
Quantity 40 -0.3%
Value US$25,360
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
631.26
Quantity 40 -0.3%
Value US$25,250
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
629.33
Quantity 42 -0.3%
Value US$26,432
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
628.41
Quantity 76 -0.6%
Value US$47,759
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
627.79
Quantity 56 -0.4%
Value US$35,156
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
626.05
Quantity 7 -0.1%
Value US$4,382
US Dexcom Inc (DXCM)
Transaction date
Planned sale
Price
625.32
Quantity 124 -0.9%
Value US$77,540
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-04 2026-08-03
US Dexcom Inc (DXCM)
PlS Planned sale
58,422 -43.9%
369.08
US$1,747,922 		58,422 -43.9% 369.08 US$1,747,922
2026-08-03 2026-08-03
US Dexcom Inc (DXCM)
PrS Proposed sale
56,697
343.37
US$112,895 		56,697 343.37 US$112,895
2026-08-04 2026-07-31
US Dexcom Inc (DXCM)
PlS Planned sale
97,694 +48.1%
86.42
US$4,730,759 		97,694 +48.1% 86.42 US$4,730,759
2026-07-31 2026-07-31
US Dexcom Inc (DXCM)
PrS Proposed sale
2,000
80.00
US$160,000 		2,000 80.00 US$160,000
2026-06-17 2026-06-15
US Dexcom Inc (DXCM)
PlS Planned sale
199 -0.4%
74.82
US$14,889 		199 -0.4% 74.82 US$14,889
2026-06-17 2026-06-15
US Dexcom Inc (DXCM)
PlS Planned sale
3,801 -6.7%
74.10
US$281,651 		3,801 -6.7% 74.10 US$281,651
2026-06-17 2026-06-15
PlS Planned sale
2,000 -10.0%
31.07
US$62,138 		2,000 -10.0% 31.07 US$62,138
2026-06-17 2026-06-15
PlS Planned sale
1,681 -7.8%
31.07
US$52,224 		1,681 -7.8% 31.07 US$52,224
2026-06-15 2026-06-15
US Dexcom Inc (DXCM)
PrS Proposed sale
4,000
75.70
US$302,800 		4,000 75.70 US$302,800
2026-06-15 2026-06-15
PrS Proposed sale
3,681
31.00
US$114,111 		3,681 31.00 US$114,111
2025-08-18 2025-08-15
US Dexcom Inc (DXCM)
S Sale
195 -0.4%
81.54
US$15,900 		195 -0.4% 81.54 US$15,900
2025-08-18 2025-08-15
US Dexcom Inc (DXCM)
PlS Planned sale
2,555 -4.7%
81.02
US$207,003 		2,555 -4.7% 81.02 US$207,003
2025-08-15 2025-08-15
US Dexcom Inc (DXCM)
PrS Proposed sale
2,750
80.29
US$220,798 		2,750 80.29 US$220,798
2025-07-17 2025-07-15
US Dexcom Inc (DXCM)
S Sale
8 -0.0%
86.03
US$688 		8 -0.0% 86.03 US$688
2025-07-17 2025-07-15
US Dexcom Inc (DXCM)
PlS Planned sale
2,742 -4.8%
85.17
US$233,528 		2,742 -4.8% 85.17 US$233,528
2025-07-15 2025-07-15
US Dexcom Inc (DXCM)
PrS Proposed sale
2,750
86.03
US$236,582 		2,750 86.03 US$236,582
2025-06-18 2025-06-16
US Dexcom Inc (DXCM)
PlS Planned sale
2,750 -4.6%
83.13
US$228,605 		2,750 -4.6% 83.13 US$228,605
2025-06-16 2025-06-16
US Dexcom Inc (DXCM)
PrS Proposed sale
2,750
82.80
US$227,700 		2,750 82.80 US$227,700
2024-06-20 2024-06-18
US Dexcom Inc (DXCM)
PlS Planned sale
299 -0.5%
117.25
US$35,056 		299 -0.5% 117.25 US$35,056
2024-06-20 2024-06-18
US Dexcom Inc (DXCM)
PlS Planned sale
3,007 -5.0%
116.75
US$351,065 		3,007 -5.0% 116.75 US$351,065
2024-06-18 2024-06-18
US Dexcom Inc (DXCM)
PrS Proposed sale
3,306
116.53
US$385,248 		3,306 116.53 US$385,248
2024-06-20 2024-06-17
US Dexcom Inc (DXCM)
PlS Planned sale
475 -0.8%
117.77
US$55,942 		475 -0.8% 117.77 US$55,942
2024-06-20 2024-06-17
US Dexcom Inc (DXCM)
PlS Planned sale
2,212 -3.5%
117.16
US$259,159 		2,212 -3.5% 117.16 US$259,159
2024-06-20 2024-06-17
US Dexcom Inc (DXCM)
PlS Planned sale
7 -0.0%
115.18
US$806 		7 -0.0% 115.18 US$806
2024-06-17 2024-06-17
US Dexcom Inc (DXCM)
PrS Proposed sale
2,694
115.18
US$310,295 		2,694 115.18 US$310,295
2024-03-01 2024-02-29
B Purchase
500 +6.2%
56.90
US$28,450 		500 +6.2% 56.90 US$28,450
2023-05-25 2023-05-25
US Dexcom Inc (DXCM)
PrS Proposed sale
10,000
113.65
US$1,136,528 		10,000 113.65 US$1,136,528
2023-04-25 2023-04-21
PlS Planned sale
1,458 -15.3%
88.78
US$129,441 		1,458 -15.3% 88.78 US$129,441
2023-04-13 2023-04-11
PlS Planned sale
1,053 -11.5%
84.63
US$89,115 		1,053 -11.5% 84.63 US$89,115
2023-04-13 2023-04-11
PlS Planned sale
4,989 -35.3%
84.29
US$420,523 		4,989 -35.3% 84.29 US$420,523
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
41 -0.3%
569.54
US$23,351 		41 -0.3% 569.54 US$23,351
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
2 -0.0%
567.35
US$1,135 		2 -0.0% 567.35 US$1,135
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
87 -0.7%
565.51
US$49,200 		87 -0.7% 565.51 US$49,200
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
65 -0.5%
564.24
US$36,675 		65 -0.5% 564.24 US$36,675
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
116 -0.9%
562.79
US$65,283 		116 -0.9% 562.79 US$65,283
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
78 -0.6%
561.85
US$43,824 		78 -0.6% 561.85 US$43,824
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
70 -0.5%
558.78
US$39,115 		70 -0.5% 558.78 US$39,115
2021-12-02 2021-12-01
US Dexcom Inc (DXCM)
PlS Planned sale
41 -0.3%
556.89
US$22,832 		41 -0.3% 556.89 US$22,832
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
40 -0.3%
634.01
US$25,360 		40 -0.3% 634.01 US$25,360
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
40 -0.3%
631.26
US$25,250 		40 -0.3% 631.26 US$25,250
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
42 -0.3%
629.33
US$26,432 		42 -0.3% 629.33 US$26,432
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
76 -0.6%
628.41
US$47,759 		76 -0.6% 628.41 US$47,759
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
56 -0.4%
627.79
US$35,156 		56 -0.4% 627.79 US$35,156
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
7 -0.1%
626.05
US$4,382 		7 -0.1% 626.05 US$4,382
2021-11-02 2021-11-01
US Dexcom Inc (DXCM)
PlS Planned sale
124 -0.9%
625.32
US$77,540 		124 -0.9% 625.32 US$77,540